Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

NIH 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 2Gynecologic 2Gastrointestinal 2

Conditions

Neoplasms 51Lung Neoplasms 32Lymphoma 31Breast Neoplasms 29Multiple Myeloma 27Prostatic Neoplasms 25Melanoma 23Carcinoma, Non-Small-Cell Lung 23Leukemia, Myeloid, Acute 22Neoplasm Metastasis 21Ovarian Neoplasms 20Lymphoma, Non-Hodgkin 20Hematologic Neoplasms 20Glioma 18Pancreatic Neoplasms 17Urinary Bladder Neoplasms 16Neuroblastoma 15Colorectal Neoplasms 15Burkitt Lymphoma 15Carcinoma, Renal Cell 14Sarcoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Colonic Neoplasms 13Leukemia, Lymphocytic, Chronic, B-Cell 12Carcinoma 12Brain Neoplasms 12Triple Negative Breast Neoplasms 11Stomach Neoplasms 11Squamous Cell Carcinoma of Head and Neck 11Oropharyngeal Neoplasms 11

Interventions

fludarabine 1avelumab 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Thymoma × 30 days × Clear all
NCT01950572 2026-06-05

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

National Institutes of Health Clinical Center (CC)

Recruiting
1,000 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Biliary Tract Neoplasms, Lung Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thymoma

NCT06885697 2026-06-05

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
100 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thymoma, Thymus Neoplasms

NCT03076554 2026-05-29

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
56 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡